21 November 2017
News and Views
Links and Services
A study in July's issue of Inflammatory Bowel Diseases investigates methotrexate for maintenance of remission in chronic active Crohn's disease.
According to current guidelines methotrexate should be considered as a second-line immunomodulato
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors